Online security company Toopher has been sold to Salesforce, according to a note from its co-founders that appeared Wednesday on the company’s website. San Francisco-based Salesforce confirmed the sale. Terms were not disclosed.
Toopher developed a technology that uses a person’s... Read more »
Gelesis may have raised $22 million just last week, but apparently it had more up its sleeve than just a private equity financing.
The Boston-based startup filed papers this afternoon to go public. It intends to use the proceeds... Read more »
Wisconsin’s top life sciences trade group has named its second new CEO in the past seven months.
Bioforward said today that Lisa Johnson, currently the vice president of entrepreneurship and innovation for the Wisconsin Economic Development Corp. (WEDC), will take over... Read more »
San Diego-based NuVasive (NASDAQ: NUVA), which makes specialized surgical products for use in spinal surgery, said today that chairman and CEO Alex Lukianov has resigned over violations of the company’s personnel and expense reimbursement policies.
Greg Lucier, a NuVasive board... Read more »
The largest smart grid demonstration project in the U.S., covering about a dozen utilities in five Northwest states, has shown how adding more information at all levels of the electricity system can improve efficiency and potentially lower costs.
But the project,... Read more »
It is the best of times to be an entrepreneur now, with easy money to be had, but gloom lurks on the horizon, according to Gary Vaynerchuk.
“This is not going to last,” he said.
On Tuesday, the investor and entrepreneur... Read more »
Innovation news in Texas started off the year with the announcement that billionaire IT entrepreneur and “Shark Tank” judge Mark Cuban would judge at the Impact Pediatric Health pitch day at South By Southwest. The first quarter of the year concluded... Read more »
After five years of bootstrapping his startup, Instancy, Harvey Singh’s company has a finished education software product, revenue, and a growing roster of employees. As Singh looks overseas to expand Instancy’s sales reach, he says he is now ready for... Read more »
Pushing a cancer therapy through clinical trials typically takes years and millions of dollars. But before trial organizers can even begin evaluating a drug’s safety and effectiveness in humans, they must first, of course, sign up patients to test it.
Easier... Read more »
[Updated, 8:55 am ET] It’s been a strange journey for Chris Garabedian. As the CEO of Sarepta Therapeutics, he steered the company from a biotech afterthought to one of Wall Street’s darlings, earning the support of a Duchenne Muscular... Read more »